Skip to content
10-K

Annual Report

Amneal Pharmaceuticals, Inc. AMRX

0001723128-26-000011

← back to feed
Filed
Feb 27, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 13, 2026 314.63M sh
Shares Diluted FY 2025 · Dec 31, 2025 324.81M sh
Shares Diluted FY 2025 · Dec 31, 2024 308.98M sh
Shares Diluted FY 2025 · Dec 31, 2023 176.14M sh
Capex FY 2025 · Dec 31, 2025 $70.06M
Capex FY 2025 · Dec 31, 2024 $51.92M
Capex FY 2025 · Dec 31, 2023 $43.22M
Operating Cash Flow FY 2025 · Dec 31, 2025 $339.99M
Operating Cash Flow FY 2025 · Dec 31, 2024 $295.1M
Operating Cash Flow FY 2025 · Dec 31, 2023 $345.58M
Long Term Debt FY 2025 · Dec 31, 2025 $2.57B
Long Term Debt FY 2025 · Dec 31, 2024 $2.16B
Short Term Debt FY 2025 · Dec 31, 2025 $6.76M
Short Term Debt FY 2025 · Dec 31, 2024 $224.21M
Cash And Equivalents FY 2025 · Dec 31, 2025 $282.03M
Cash And Equivalents FY 2025 · Dec 31, 2024 $110.55M
Cash And Equivalents FY 2025 · Dec 31, 2023 $91.54M
Stockholders Equity FY 2025 · Dec 31, 2025 −$70.79M
Stockholders Equity FY 2025 · Dec 31, 2024 −$109.27M
Current Liabilities FY 2025 · Dec 31, 2025 $881.63M
Current Liabilities FY 2025 · Dec 31, 2024 $1.13B
Current Assets FY 2025 · Dec 31, 2025 $1.91B
Current Assets FY 2025 · Dec 31, 2024 $1.59B
Total Assets FY 2025 · Dec 31, 2025 $3.68B
Total Assets FY 2025 · Dec 31, 2024 $3.5B
Eps Diluted FY 2025 · Dec 31, 2025 $0.22
Eps Diluted FY 2025 · Dec 31, 2024 −$0.38
Eps Diluted FY 2025 · Dec 31, 2023 −$0.48
Eps Basic FY 2025 · Dec 31, 2025 $0.23
Eps Basic FY 2025 · Dec 31, 2024 −$0.38
Eps Basic FY 2025 · Dec 31, 2023 −$0.48
Sga Expense FY 2025 · Dec 31, 2025 $526.83M
Sga Expense FY 2025 · Dec 31, 2024 $476.44M
Sga Expense FY 2025 · Dec 31, 2023 $429.68M
Rd Expense FY 2025 · Dec 31, 2025 $186.18M
Rd Expense FY 2025 · Dec 31, 2024 $190.71M
Rd Expense FY 2025 · Dec 31, 2023 $163.95M
Net Income FY 2025 · Dec 31, 2025 $72.06M
Net Income FY 2025 · Dec 31, 2024 −$116.89M
Net Income restated FY 2025 · Dec 31, 2023 −$83.99M
Operating Income FY 2025 · Dec 31, 2025 $394.1M
Operating Income FY 2025 · Dec 31, 2024 $249.33M
Operating Income FY 2025 · Dec 31, 2023 $204.37M
Gross Profit FY 2025 · Dec 31, 2025 $1.11B
Gross Profit FY 2025 · Dec 31, 2024 $1.02B
Gross Profit FY 2025 · Dec 31, 2023 $820.57M
Cost Of Revenue FY 2025 · Dec 31, 2025 $1.91B
Cost Of Revenue FY 2025 · Dec 31, 2024 $1.77B
Cost Of Revenue FY 2025 · Dec 31, 2023 $1.57B
Revenue FY 2025 · Dec 31, 2025 $3.02B
Revenue FY 2025 · Dec 31, 2024 $2.79B
Revenue FY 2025 · Dec 31, 2023 $2.39B